Open Government Portal
Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and …
IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential …
Learn more about drugs and vaccines being developed or authorized for COVID-19.
The purpose of this notice is to communicate the types of testing technologies that Health Canada considers are a priority …
During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect …
The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials …
Canadian businesses, non-profit organizations, or charities who have seen a drop in revenue during the COVID-19 pandemic may …
The data contained in the dashboard describes the COVID-19 cases and deaths by province and health regions.
Appearance of Minister of Labour Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with …
Honourable Ahmed Hussen, Minister of Families, Children and Social Development, at an appearance before the House of Commons, Standing Committee …